Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Republic of Korea: Our Best Clinics and Costs 2026

South Korean HIPEC success rates remain among the highest globally, showing a 10-year progression-free survival of 53.6% for ovarian cancer patients. Specialized tertiary centers reports a 0% postoperative mortality rate, reflecting exceptional surgical safety and precision during complex cytoreductive procedures in JCI-accredited facilities.

• Ovarian cancer survival: HIPEC extends median overall survival to 61.8 months during interval surgery.
• Gastric cancer outcomes: Complete tumor removal boosts median survival to 34 months for patients.
• Colorectal cancer edge: Combined HIPEC therapy achieves 41.5 months median survival vs 16.8 months traditionally.
• Surgical safety record: Major Korean hospitals maintain 0% mortality with approximately 20% morbidity rates.

Bookimed Expert Insight: Data from top-tier institutions like Severance Hospital highlights a critical volume-outcome relationship. These facilities manage 1.6 million outpatients annually, allowing surgeons to refine HIPEC techniques through hundreds of cases. This high volume directly correlates with their recorded 0% mortality rates in several clinical trials.

Patient Consensus: Patients report that Korean specialists achieve 70–85% 5-year survival for rare conditions like PMP. Many emphasize the importance of early intervention, noting better outcomes when peritoneal index scores stay under 10.

HIPEC is covered by South Koreas National Health Insurance (NHI) for eligible citizens and residents. Through the Special Case for Cancer Patients program, medical costs for approved indications like gastric or ovarian cancer are reduced to a 5% co-payment at JCI-accredited facilities.

• Co-payment rate: Patients typically pay 5% of costs for medically indicated cancer treatments.
• NHI eligibility: Coverage depends on cancer type, with gastric and ovarian being most common.
• International patients: Medical tourists usually pay full price, ranging $23,500 to $35,500.
• Reimbursement status: Approved since 2013, though some cases fall under selective reimbursement criteria.

Bookimed Expert Insight: High-volume centers like Severance Hospital serve over 1.6 million outpatients annually. This massive scale often leads to more streamlined insurance processing for complex procedures. Choosing a tertiary hospital ensures your HIPEC protocol matches the strict NHI standards for potential coverage.

Patient Consensus: Patients report that getting written pre-approval from the NHI is essential for coverage. While surgeons recommend the procedure, the hospital administrative office handles the actual insurance approval history.

Samsung Medical Center, ASAN Medical Center, and Severance Hospital are the top-rated facilities for HIPEC in South Korea. These centers rank among the worlds best for oncology, utilizing multidisciplinary teams to treat advanced abdominal cancers with combined cytoreductive surgery and heated chemotherapy.

• Samsung Medical Center: Ranked 3rd globally for oncology, performing high volumes of advanced HIPEC procedures.
• Severance Hospital: JCI-accredited facility featuring the specialized Yonsei Cancer Center for complex gastric cases.
• ASAN Medical Center: Leading Asia-Pacific research hub recognized for expertise in gastroenterology and abdominal oncology.
• Gachon University Gil: Top-tier Incheon facility providing international-level medical services and specialized multidisciplinary oncology teams.

Bookimed Expert Insight: While the Big 5 hospitals in Seoul dominate global rankings, Severance Hospital stands out for international patients due to its 1.6 million annual outpatient capacity and extensive JCI-accredited infrastructure. Choosing a high-volume center is critical, as outcomes for HIPEC correlate directly with a surgeons annual case count.

Patient Consensus: Patients emphasize prioritizing the Big 5 hospitals for refined 15-year protocols. Many recommend securing telemedicine second opinions and verifying that surgeons perform at least 50 HIPEC cases annually.

Surgeons in South Korea utilize Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to treat advanced abdominal malignancies including ovarian, colorectal, and gastric cancers. Major centers like Severance Hospital apply this heated chemotherapy following cytoreductive surgery to target peritoneal metastases and rare conditions like pseudomyxoma peritonei.

• Ovarian cancer: Primary treatment for stage III and IV patients with peritoneal carcinomatosis.
• Colorectal cancer: Targeted therapy for stage IV patients with limited peritoneal seeding.
• Gastric cancer: Applied to treat advanced stomach cancer and prevent abdominal recurrence.
• Appendiceal tumors: Standard care for mucinous tumors and rare peritoneal mesothelioma.

Bookimed Expert Insight: Clinical data shows Korean centers like Severance Hospital often adopt more assertive HIPEC protocols for borderline ovarian tumors. While Western facilities may hesitate, South Korean surgeons utilize their high volume of 4 million annual patients to refine these aggressive surgical techniques. This experience often translates to shorter wait times for international patients seeking immediate intervention.

Patient Consensus: Patients report that while the 6-week recovery involves significant abdominal pain, the aggressive approach in Seoul provides options for stage IV cases. Many recommend arranging local help for daily tasks due to the intense post-operative fatigue.

Recovery after HIPEC in South Korea follows a structured clinical pathway focused on early mobilization and intensive monitoring. Patients typically spend 5–7 days in JCI-accredited hospitals like Severance Hospital before discharge. Full physical stamina and basic function usually return within 4 to 8 weeks.

• Hospital stay: Expect 5–7 days post-op in specialized oncology wards or intensive care units.
• Activity restrictions: Avoid lifting over 10 pounds for 6–8 weeks to prevent abdominal issues.
• Nutritional transition: Start with clear liquids, progressing to small, high-protein meals to combat appetite loss.
• Follow-up schedule: Attend weekly visits for the first month, followed by monthly clinical check-ups.

Bookimed Expert Insight: South Korean centers like Gachon University Gil Medical Center prioritize faster discharge times than Western hospitals. While patients leave the hospital within 7 days, the most significant drop in blood counts occurs around day 10. You should arrange local stay in Incheon or Seoul for at least 14 days to manage this infection risk safely.

Patient Consensus: Patients often find that incisional pain and severe fatigue peak between weeks 2 and 4. Reliable home support is essential during this period to manage wound care and identify early signs of bowel obstruction.

Medical tourists should plan for a 21 to 30 day stay in South Korea for HIPEC treatment. This timeframe encompasses a 3–7 day pre-operative phase, 7–14 days of inpatient hospitalization for monitoring, and a final 7–14 day local recovery period before long-haul travel.

• Pre-operative prep: Expect 3 to 7 days for diagnostic imaging and surgeon consultations in Seoul.
• Hospitalization phase: Clinical monitoring typically lasts 7 to 14 days following the complex HIPEC surgery.
• Post-discharge recovery: Patients must remain local for 7 to 14 days for wound care and follow-ups.
• Flight clearance: Surgeons generally advise waiting at least 14 days after discharge before flying home.

Bookimed Expert Insight: Data from top-tier facilities like Severance Hospital shows that high-volume centers often streamline the pre-op phase. While 30 days is a safe buffer, Seoul-based international coordinators can sometimes compress the initial testing window to 3 days. Always book flexible return flights to accommodate these specialist-driven timeline shifts.

Patient Consensus: Travelers emphasize the importance of having a companion stay for the full duration. Mobility is often limited during the first week after hospital discharge, making professional recovery hotels or assisted living highly valuable.

Patients are not candidates for HIPEC in Korea if they have cancer spread outside the abdominal cavity, such as to the lungs or brain. Severe comorbidities, an ECOG performance status over 2, or a Peritoneal Cancer Index score exceeding 20 typically disqualify patients from this intensive 6-12 hour surgery.

• Extra-peritoneal metastasis: Cancer involving the lungs, bones, or brain disqualifies patients from the procedure.
• High disease burden: A Peritoneal Cancer Index (PCI) score above 20 usually indicates unresectable disease.
• Poor performance: Patients with an ECOG status higher than 2 lack the required physical stamina.
• Incomplete cytoreduction: If surgeons cannot achieve optimal debulking, HIPEC is generally not performed.

Bookimed Expert Insight: Korean centers like Severance Hospital and Gachon University Gil Medical Center use rigorous pre-surgical staging. They prioritize full cytoreduction potential. If a CT or PET scan shows tumors on the porta hepatis or extensive small bowel involvement, they often recommend systemic chemotherapy instead. This high selectivity helps maintain their status in the Newsweek World’s Best Hospitals rankings.

Patient Consensus: Many patients find that Korean clinics are very strict about the 20-point PCI threshold. Those with metastatic spread to the liver or lungs should expect a denial and may need to focus on systemic treatments first.